Open AccessAssessment of genetically modified maize MIR 604 for renewal authorisation under Regulation ( EC ) No 1829/2003 (application EFSA ‐ GMO ‐ RX ‐013)
Author(s) -
Naegeli Hanspeter,
Bresson JeanLouis,
Dalmay Tamas,
Dewhurst Ian Crawford,
Epstein Michelle M,
Firbank Leslie George,
Guerche Philippe,
Hejatko Jan,
Moreno Francisco Javier,
Mullins Ewen,
Nogué Fabien,
Rostoks Nils,
Sánchez Serrano Jose Juan,
Savoini Giovanni,
Veromann Eve,
Veronesi Fabio,
Álvarez Fernando,
Ardizzone Michele,
Raffaello Tommaso
Publication year - 2019
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2019.5846
Subject(s) - context (archaeology) , authorization , microbiology and biotechnology , genetically modified maize , agricultural science , genetically modified organism , risk assessment , genetically modified crops , toxicology , biology , computer science , transgene , genetics , paleontology , computer security , gene
Following the submission of application EFSA ‐ GMO ‐ RX ‐013 under Regulation ( EC ) No 1829/2003 from Syngenta Crop Protection NV / SA , the EFSA Panel on Genetically Modified Organisms ( GMO ) was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application for the insect‐resistant genetically modified maize MIR 604, for food and feed uses, excluding cultivation within the EU . The data received in the context of this renewal application contained post‐market environmental monitoring reports, a systematic search and evaluation of literature, updated bioinformatic analyses, and additional documents or studies performed by or on behalf of the applicant. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the context of the original application. Under the assumption that the DNA sequence of the event in maize MIR 604 considered for renewal is identical to the corrected sequence of the originally assessed event, the GMO Panel concludes that there is no evidence in renewal application EFSA ‐ GMO ‐ RX ‐013 for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on maize MIR 604.